Adela Deaconu is the Head of Legal Group Exports Controls in Legal Compliance department of Royal Philips in the Netherlands.
In this role, Adela is the binding factor for export controls and sanctions compliance programs across all Royal Philips businesses, markets and functions worldwide.

Passionate about bringing health solutions to most remote areas of the world, Adela understands how to deliver sustainable & compliant solutions in the global geopolitical echo-system navigating complex areas of cross-jurisdictional sanctions laws and regulation.

Adela is leading a global team of subject matter experts in export controls and sanctions and advising and guiding the Philips Export Control Officer Network around the world. She is representing Philips towards various governmental and non-governmental bodies worldwide and actively participating in export controls and sanctions regulatory and policy matters.
Adela is an export controls and sanctions professional with expertise and experience in leading operations, projects and teams in semiconductions, consumer, personal health and healthcare industry. Areas of expertise cover compliance framework management, license management, risk management, government affairs, M&A due diligence, CFIUS, encryption controls, sanctions, under EU, US and other legal jurisdictions relevant for Philips.

In 2017 Adela has been nominated and received the Award for Excellence in Export Controls – Netherlands as part of the AI 2017 Influential Businesswoman Awards.

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries.